Home › Canada › TSX stocks › CNR

Canadian National Railway Company (TSX: CNR)

CNR trades on the Toronto Stock Exchange in Industrial Products & Services, headquartered in Quebec. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · October 14, 2026

C$170.78

+0.93% on the day

Market cap (C$)

C$102.3B

TMX list, September 30, 2026

Market cap (US$)

US$71.7B

Large cap at 1.4263 C$/US$

1-year return

+29.1%

+25.8% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for CNR.TO, last bar 2026-10-14, computed by Sophia Capital. Website: Wikidata.

Profile

Field	Value
Ticker	CNR on the Toronto Stock Exchange
Yahoo symbol	CNR.TO
Sector	Industrial Products & Services
Headquarters	Quebec
Listed	1995-11-17
Listing type	IPO
Shares outstanding	604,092,195
Also listed on	NYSE
Index membership	S&P/TSX 60
SEC CIK	0000016868
Website	www.cn.ca
US listing	CNI

Returns

Window	Return
1 day	+0.9%
1 week	+1.4%
1 month	+0.6%
3 months	-2.7%
6 months	+10.7%
Year to date	+25.8%
1 year	+29.1%
From 52-week high	-7.1%
52-week range	C$128.08 to C$183.92

Links

Search filings on SEDAR+TMX Money quote Yahoo Finance SEC EDGAR filings Company website Open in the app

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

88 documents in 11 types. Each title links to the document at its source.

Annual financial statements (2)

Document	Type	Filed
1. receiving the consolidated financial statements for the year ended December 31, 2024, and the auditors’ Period 2024-12-31	Annual financial statements (6-K)	2025-03-26
CN ANNUAL 2024 CONSOLIDATED FINANCIAL STATEMENTS AND NOTES THERETO	Annual financial statements (6-K)	2025-02-04

Interim financial statements (8)

Document	Type	Filed
CN Q2 2026 CONSOLIDATED FINANCIAL STATEMENTS AND NOTES THERETO	Interim financial statements (6-K)	2026-07-24
CN Q1 2026 CONSOLIDATED FINANCIAL STATEMENTS AND NOTES THERETO	Interim financial statements (6-K)	2026-04-29
CN Q4 2025 CONSOLIDATED FINANCIAL STATEMENTS AND NOTES THERETO	Interim financial statements (6-K)	2026-01-30
CN Q3 2025 CONSOLIDATED FINANCIAL STATEMENTS AND NOTES THERETO	Interim financial statements (6-K)	2025-10-31

MD&A (9)

Document	Type	Filed
CN ANNUAL 2025 MANAGEMENT'S DISCUSSION AND ANALYSIS	MD&A (annual) (6-K)	2026-02-04
CN ANNUAL 2025 MANAGEMENT'S DISCUSSION AND ANALYSIS	MD&A (annual) (6-K)	2026-02-04
CN ANNUAL 2024 MANAGEMENT'S DISCUSSION AND ANALYSIS	MD&A (annual) (6-K)	2025-02-04
CN Q2 2026 MANAGEMENT'S DISCUSSION AND ANALYSIS	MD&A (interim) (6-K)	2026-07-24

News release (12)

Document	Type	Filed
CN Q2 2026 EARNINGS NEWS RELEASE	News release (6-K)	2026-07-24
Press Release – CN announces US$750 million debt offering	News release (6-K)	2026-05-08
CN Q1 2026 EARNINGS NEWS RELEASE	News release (6-K)	2026-04-29
CN Q4 2025 EARNINGS NEWS RELEASE	News release (6-K)	2026-01-30

Management information circular / proxy (6)

Document	Type	Filed
Notice of Availability of Materials Period 2025-12-31	Management information circular (6-K)	2026-03-25
Management Information Circular	Management information circular (6-K)	2026-03-25
Notice of Annual Meeting of Shareholders	Notice of meeting (6-K)	2026-03-25
Notice of Annual Meeting of Shareholders Period 2024-12-31	Notice of meeting (6-K)	2025-03-26

Prospectus (5)

Document	Type	Filed
F-10	Prospectus (short form) (F-10)	2026-04-29
SUPPL	Prospectus supplement (SUPPL)	2026-05-08
SUPPL	Prospectus supplement (SUPPL)	2026-05-07
SUPPL	Prospectus supplement (SUPPL)	2025-11-07

Annual report (3)

Document	Type	Filed
FORM 40-F Period 2025-12-31	Annual report (40-F) (40-F)	2026-02-04
FORM 40-F Period 2024-12-31	Annual report (40-F) (40-F)	2025-02-04
Annual Report	Annual report to shareholders (6-K)	2026-03-25

Early warning / ownership (2)

Document	Type	Filed
Schedule 13D amendment	Schedule 13D (SCHEDULE 13D/A)	2025-04-30
Schedule 13D amendment	Schedule 13D (SC 13D/A)	2024-11-04

Insider report (1)

Document	Type	Filed
Form 144	Form 144 (144)	2025-12-23

Certification (14)

Document	Type	Filed
CN ANNUAL 2025 CEO AND CFO CERTIFICATES	Certification (52-109F1) (6-K)	2026-02-04
CN ANNUAL 2024 CEO AND CFO CERTIFICATES	Certification (52-109F1) (6-K)	2025-02-04
CN Q2 2026 CEO AND CFO CERTIFICATES	Certification (52-109F2) (6-K)	2026-07-24
CN Q1 2026 CEO AND CFO CERTIFICATES	Certification (52-109F2) (6-K)	2026-04-29

Other (26)

Document	Type	Filed
EXHIBIT 5.1	Consent (F-10)	2026-04-29
Consent of KPMG LLP Period 2025-12-31	Consent (40-F)	2026-02-04
Consent Period 2024-12-31	Consent (40-F)	2025-02-04
EXHIBIT 97 Period 2025-12-31	Material contract / governance (40-F)	2026-02-04

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

Peers in Industrial Products & Services

Ticker	Company	Exchange	Market cap (C$)	1 month	1 year
CP	Canadian Pacific Kansas City Limited	TSX	C$106.1B	-1.8%	+17.0%
WCN	Waste Connections, Inc.	TSX	C$55.1B	-0.4%	-7.7%
BBD	Bombardier Inc.	TSX	C$32.0B	-6.2%	+52.5%
GFL	GFL Environmental Inc.	TSX	C$25.2B	+3.3%	-4.8%
MG	Magna International Inc.	TSX	C$24.0B	+1.6%	+50.4%

The app has the price chart, every filing, private raises and the full peer set for CNR.

Open in the app